David M Brown, Rachel E Sobel, Kiliana Suzart-Woischnik, Nick Boucher, Julius Asubonteng, Hadi Moini, Nitika Aggarwal, Suzanne Green, Angelika Manthripragada
{"title":"阿非利西普预充注射器和小瓶注射后的眼内炎症。","authors":"David M Brown, Rachel E Sobel, Kiliana Suzart-Woischnik, Nick Boucher, Julius Asubonteng, Hadi Moini, Nitika Aggarwal, Suzanne Green, Angelika Manthripragada","doi":"10.1016/j.oret.2025.03.002","DOIUrl":null,"url":null,"abstract":"<p><p>In this observational cohort study, incidence of intraocular inflammation following intravitreal injection in the Vestrum Health database was significantly lower with aflibercept 2-mg (EYLEA) prefilled syringes versus vials from 2020 to 2022 (P < 0.0001).</p>","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":" ","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Intraocular Inflammation After Aflibercept Prefilled Syringe and Vial Injections.\",\"authors\":\"David M Brown, Rachel E Sobel, Kiliana Suzart-Woischnik, Nick Boucher, Julius Asubonteng, Hadi Moini, Nitika Aggarwal, Suzanne Green, Angelika Manthripragada\",\"doi\":\"10.1016/j.oret.2025.03.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this observational cohort study, incidence of intraocular inflammation following intravitreal injection in the Vestrum Health database was significantly lower with aflibercept 2-mg (EYLEA) prefilled syringes versus vials from 2020 to 2022 (P < 0.0001).</p>\",\"PeriodicalId\":19501,\"journal\":{\"name\":\"Ophthalmology. Retina\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmology. Retina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.oret.2025.03.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology. Retina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.oret.2025.03.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Intraocular Inflammation After Aflibercept Prefilled Syringe and Vial Injections.
In this observational cohort study, incidence of intraocular inflammation following intravitreal injection in the Vestrum Health database was significantly lower with aflibercept 2-mg (EYLEA) prefilled syringes versus vials from 2020 to 2022 (P < 0.0001).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
